Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
This is accompanied by p53/p21/BAX induction
superior to that observed with 6-thioguanine treatment
Gilteritinib inhibits the activity of eight of the 78 tested kinases by over 50% at concentrations of either 1 nM (FLT3
In a colorectal carcinoma (Colo205) xenograft study
Smiles: CC1(C)CC[C@@]2(CC[C@]3(C)C(=CC[C@H]4[C@@]3(C)CC[C@H]3[C@](C)(CO)[C@H](CC[C@@]34C)O[C@@H]3OC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@@H]2C1)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O
Voruciclib l Enzalutamide D6 This is accompanied by p53/p21/BAXVoruciclib is an orally active and selective CDK inhibitor with Ki values of 0. 626 nM 9. 1 nM. Voruciclib potently blocks CDK9, the transcriptional regulator of MCL 1. Voruciclib represses expression of MCL 1 in multiple models of diffuse large B cell lymphoma (DLBCL). Product information CAS Number: 1000023 04 0 Molecular Weight: 469. 84 Formula: C22H19ClF3NO5 Chemical Name: 2 [2 chloro 4 (trifluoromethyl)phenyl] 5,7 dihydroxy 8 [(2R,3S) 2
US$ 10.00
US$ 45.00
US$ 550.00
US$ 1120.00
US$ 2300.00
US$ 47.45
US$ 97.17
US$ 393.50
US$ 1303.99
US$ 450.00
US$ 417.00
US$ 351.50